|
Name: Nicocodeine
Type: Opioid
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
|
IV. History
Nicocodeine, a synthetic opioid, was first synthesized in the early 20th century. It was developed for its analgesic properties and used in medical settings. The compound's introduction reflects early research into opioid analgesics. Nicocodeine's use has declined due to the development of more effective and safer analgesics.
|
|
V. Legal Information
Nicocodeine, an opioid derivative, is regulated due to its potential for abuse. Its legal status varies by country, with regulations focused on its use in medical settings and preventing misuse.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Nicocodeine is an opioid used for pain relief and cough suppression. It acts as a downer, causing sedation and respiratory depression. Short-term use provides effective pain management, but long-term use can lead to addiction and tolerance. Overdose risks include severe respiratory depression and potential death. Safe use requires precise dosing and medical supervision. Recent research examines its efficacy and safety compared to other opioids.  |
|
VII. Psychological Effects
Nicocodeine, an opioid, affects opioid receptors to produce analgesia and mood alteration. Immediate effects include euphoria and cognitive impairment, with long-term use carrying risks of dependence and mental health issues. Research examines its efficacy and potential for abuse.
 |
|
VIII. Culture
Nicocodeine is a codeine derivative used for cough suppression, classifying it as a downer. Short-term use provides effective cough relief, while long-term use can lead to dependence, tolerance, and severe health issues. Overdose risks include severe respiratory depression and potentially fatal outcomes. Safe dosages are typically prescribed and controlled by medical professionals. Recent research emphasizes its efficacy in cough suppression but warns of potential abuse and dependence risks. Physical effects include drowsiness, constricted pupils, and respiratory depression.
 |